Beneficial Effect of Human Induced Pluripotent Stem Cell-Derived Neural Precursors in Spinal Cord Injury Repair
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
25259685
DOI
10.3727/096368914x684042
PII: content-CT-1214_Romanyuk
Knihovny.cz E-zdroje
- MeSH
- 2',3'-cyklické nukleotidfosfodiesterasy genetika metabolismus MeSH
- buněčná diferenciace MeSH
- chování zvířat MeSH
- gliový fibrilární kyselý protein genetika metabolismus MeSH
- hematoencefalická bariéra metabolismus MeSH
- indukované pluripotentní kmenové buňky cytologie metabolismus MeSH
- krysa rodu Rattus MeSH
- kultivované buňky MeSH
- kvantitativní polymerázová řetězová reakce MeSH
- lidé MeSH
- nervové kmenové buňky cytologie transplantace MeSH
- neurotrofní faktory genetika metabolismus MeSH
- pohyb buněk MeSH
- pohybová aktivita MeSH
- poranění míchy etiologie terapie MeSH
- potkani Wistar MeSH
- protein doublecortin MeSH
- proteiny asociované s mikrotubuly genetika metabolismus MeSH
- transkripční faktory genetika metabolismus MeSH
- transplantace heterologní MeSH
- tubulin genetika metabolismus MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- 2',3'-cyklické nukleotidfosfodiesterasy MeSH
- Dcx protein, rat MeSH Prohlížeč
- gliový fibrilární kyselý protein MeSH
- MAP2 protein, human MeSH Prohlížeč
- neurotrofní faktory MeSH
- protein doublecortin MeSH
- proteiny asociované s mikrotubuly MeSH
- transkripční faktory MeSH
- tubulin MeSH
Despite advances in our understanding and research of induced pluripotent stem cells (iPSCs), their use in clinical practice is still limited due to lack of preclinical experiments. Neural precursors (NPs) derived from a clone of human iPSCs (IMR90) were used to treat a rat spinal cord lesion 1 week after induction. Functional recovery was evaluated using the BBB, beam walking, rotarod, and plantar tests. Lesion morphology, endogenous axonal sprouting, graft survival, and iPSC-NP differentiation were analyzed immunohistochemically. Quantitative polymerase chain reaction (qPCR) was used to evaluate the effect of transplanted iPSC-NPs on endogenous regenerative processes and also to monitor their behavior after transplantation. Human iPSC-NPs robustly survived in the lesion, migrated, and partially filled the lesion cavity during the entire period of observation. Transplanted animals displayed significant motor improvement already from the second week after the transplantation of iPSC-NPs. qPCR revealed the increased expression of human neurotrophins 8 weeks after transplantation. Simultaneously, the white and gray matter were spared in the host tissue. The grafted cells were immunohistochemically positive for doublecortin, MAP2, βIII-tubulin, GFAP, and CNPase 8 weeks after transplantation. Human iPSC-NPs further matured, and 17 weeks after transplantation differentiated toward interneurons, dopaminergic neurons, serotoninergic neurons, and ChAT-positive motoneurons. Human iPSC-NPs possess neurotrophic properties that are associated with significant early functional improvement and the sparing of spinal cord tissue. Their ability to differentiate into tissue-specific neurons leads to the long-term restoration of the lesioned tissue, making the cells a promising candidate for future cell-based therapy of SCI.
Citace poskytuje Crossref.org